Connect with us
Sunday,12-October-2025
Breaking News

Business

Goldman Sachs says Paytm’s current share price is a compelling entry point, ICICI Securities issue Buy rating

Published

on

Paytm continues to get the confidence of top brokerages, who are bullish about the companys “immense growth potential”. Goldman Sachs pointed out the strong growth potential for Paytms lending business, saying the firm will hit $10 billion in disbursals by FY26E, vs $900 million in FY22.

Analysts believe Paytm’s ESOP costs will gradually reduce and are currently at par with other listed tech cos in India as well as globally ICICI Securities report said that by FY26, Paytm’s monthly transacting users are likely to double

Paytm, India’s leading digital payments and financial services, continues to get ‘Buy’ calls from top brokerages. After Goldman Sachs, BofA, Morgan Stanley and Dolat Capital, ICICI Securities has also issued a Buy rating for Paytm.

Goldman Sachs had given Paytm a Buy rating, with a target price of Rs 460 on February 7. On Monday, the investment bank reiterated its Buy rating, pointing out key notes for investors. The report said that “the current share price offers a compelling entry point into India’s largest and amongst the fastest growing fintech platforms”.

ICICI Securities has now initiated coverage for Paytm and highlighted the company’s strong growth potential in terms of target addressable market (TAM), giving a “Buy’ rating and target price of Rs 1,362.

Goldman Sachs highlighted that Paytm continues to gain market share across both UPI and non-UPI payments, besides strong growth in lending business. It said Paytm’s net payments take rate or spreads have, defined as revenue less payment processing charges (PPC) as a proportion of Gross Merchandise Value (GMV) have been improving.

“Paytm’s net payments take rate (or spreads, defined as revenue less payment processing charges as a proportion of GMV) have been improving. From 8 bps in 3QFY22, we forecast spreads to widen to 11 bps by FY26E as a result of Paytm’s scale benefits; increasing share of UPI for wallet money addition; rising share of wallet for online payments (vs in-store, which have zero MDR); and rising share of device rental revenues,” the brokerage noted.

Paytm’s ESOP costs to gradually reduce, currently at par with other listed tech cos in India as well as globally.

Goldman Sachs noted that Paytm’s Employee Stock Ownership Plan (ESOP) costs will reduce gradually and is currently at par with other listed tech companies in India as well as globally.

“We forecast ESOP charge for Paytm to be highest (at Rs 3.9 billion per quarter) for first two years (when the first tranche vests, per Paytm), and then gradually reduce over the next three years. Paytm also has about 15 million un-granted options and per our estimate, the total share count could increase by 46 million (or 7 per cent of current outstanding), if all options were to be vested/granted,” said the Goldman Sachs note.

“We note that as a proportion of total operating expenses, Paytm’s ESOP cost is not significantly different vs other global platforms such as Airbnb and DoorDash, as well as recently listed India internet peers such as Zomato and PB Fintech.”

Meanwhile, ICICI Securities in its note called out Paytm’s immense growth potential in terms of target addressable market (TAM), buoyed by its leadership position in India’s digital payments ecosystem.

The brokerage said Paytm’s digital payments business has the potential to grow strongly in future, reflecting its “sizeable two-sided digital ecosystem with proven leadership in payments”.

“Paytm is well ahead in the race of digitisation, building a robust full stack technology suite integrated across the ecosystem with distinct features, high success rates, easy user interface, and customer convenience. It has an early mover advantage in rolling out wallet, FASTag, and is ahead of the curve in (skill based) online gaming, too,” said the note by ICICI Securities.

During the October-December quarter, the company saw its revenues jump by 89 per cent y-o-y to Rs 1,456 crore, EBITDA losses (before ESOP expense) came down to Rs 393 crore from Rs 488 crore during the same quarter in the previous year.

In its latest filing with the stock exchange, Paytm had shared its highest ever growth in monthly transacting users to 68.9 million users. Now, it seems analysts are bullish about this growth momentum to continue. ICICI Securities highlighted that Paytm’s monthly transacting user base (MTUs) is likely to double over FY22-26E to more than 120 million.

Paytm had said that in Q3 FY 22, its merchant payments-led GMV stood at Rs 2.5 lakh crore. Analysts at ICICI Securities forecast that Paytm’s merchant GMV would grow at 36 per cent CAGR over FY22-26E to reach Rs 30 trillion and within this, MDR linked GMV is estimated to grow at more than 25 per cent.

The brokerage noted that Paytm’s contribution margin has potential to further improve 40 per cent-46 per cent by FY24E/FY26E.

“Aided by this contribution margin, there is some visibility of EBITDA getting into positive territory post FY26E. Adjusted EBITDA margin (excluding non-cash ESOP charges) will turn positive by FY26,” it added.

Both Goldman Sachs and ICICI Securities believe that Paytm’s lending business, in which it partners financial institutions to provide loans on its platform, has the potential to grow rapidly in the medium term.

Goldman Sachs said: “We believe Paytm will be able to continue to scale its lending portfolio, and forecast $10 billion in disbursals by FY26E, vs $900 million in FY22. Paytm has continued to add new partners for its lending products over the last few quarters, suggesting to us that lenders are finding value in this partnership.”

Paytm’s lending business witnessed record growth in January 2022, maintaining the positive trend witnessed in the Q3 FY 22 earnings. Last month, Paytm registered 1.9 million loan disbursals, marking a y-o-y growth of 331 per cent; aggregating to a total value of Rs 921 crore (y-o-y growth of 334%). This also included a staggering growth in its Buy Now, Pay Later product – Paytm Postpaid.

“For Paytm’s BNPL product, 30 per cent + of the monthly sign-ups (Dec ’21 quarter) were new-to-credit customers, helping expand the credit base for Paytm’s financial partners. Per Paytm, performance of the company’s loan portfolio has resulted in higher confidence from lenders to increase the scale of this business,” it added.

Meanwhile, ICICI Securities also shared an optimistic outlook about Paytm’s lending business, estimating 18-19 million consumers (15 per cent of MTUs), and an increasing number of merchants to avail lending products through Paytm platform by FY26E.

Sharing a medium-term outlook, it estimated the total lending business revenue to grow at 61 per cent over FY22-26E.

Business

ED Seizes ₹42 Lakh, Luxury Cars In Mumbai Drug Money Laundering Probe

Published

on

Mumbai: The Enforcement Directorate (ED) seized Rs 42 lakh in cash, three luxury cars, property papers, and several digital devices during a search operation on Wednesday targeting a drug trafficking and money laundering network. The agency also froze multiple bank accounts and a locker linked to alleged drug trafficker Faisal Javed Shaikh and his wife, Alfiya Faisal Shaikh.

Officials said the searches were conducted at nine locations across Mumbai under the provisions of the Prevention of Money Laundering Act (PMLA), 2002. The operation aimed to trace the drug sale proceeds generated by a well-established narcotics network allegedly operated by the couple.

The ED initiated its money laundering probe based on a case registered by the Narcotics Control Bureau (NCB), Mumbai Zonal Unit, against multiple accused, including Faisal Shaikh, Alfiya Shaikh, and several others, including Ashik Varis Ali, Nasir Khan, Irfan Yusuf Faruqi, Azim Abu Salim Khan alias Azim Bhau, Faizan Mohd. Shafi Shaikh, and Mohd. Shahid Faridudin Chaudhary alias Baboos.

Investigators said Faisal Shaikh was procuring MD (Mephedrone) drugs from Salim Dola, a notorious drug kingpin who has been wanted by law enforcement agencies for his alleged role in large-scale narcotics trafficking. The NCB has announced a reward for information leading to Dola’s arrest.

After securing bail in the NCB case, Shaikh, described by officials as a habitual offender, was placed under preventive detention under the PIT-NDPS Act.

The ED’s probe revealed that Faisal and Alfiya Shaikh allegedly ran a structured network for the sale of MD drugs sourced from Dola. During Wednesday’s searches, the agency also covered premises connected to several individuals associated with shell companies with paper transactions exceeding Rs 100 crore, as well as firms involved in foreign outward remittances and financial dealings with the accused. Officials said these entities are being examined for their possible role in layering drug proceeds and routing the funds abroad through channels such as hawala, shell companies, and trade-based mis-invoicing.

Officials said the ED searches were critical to tracing both the “forward linkage” (movement of drug sale proceeds) and “backward linkage” (sources, beneficiaries, and conduits of funds), including whether the proceeds were channelled abroad via hawala, shell companies, or trade mis-invoicing. The seized and frozen assets including cash, bank accounts, lockers, vehicles, property documents, and digital devices are being examined under the lens of money laundering.

Continue Reading

Business

Stock markets end week on positive note; Banking, IT, and pharma stocks lead gains

Published

on

Mumbai, Oct 11: Indian equities ended the week on a positive note amid buying in banking, IT, and pharma stocks (in the last two sessions).

Investors’ sentiment remained firm toward banking stocks during the period, buoyed by the RBI monetary committee decision to keep the repo rate unchanged at 5.5 per cent, and it improved further after the government invited private sector professionals to lead the State Bank of India.

Meanwhile, pharma stocks picked up momentum at the end of the week after the US administration said that they do not plan to impose tariffs on generic drugs and signalled cutting biotech ties with flagged foreign firms, especially from China.

“Pharma stocks rallied as the US revived the Biosecure Act, aiming to cut biotech ties with flagged foreign firms, especially from China, providing a strong boost to Indian CDMOs. With the earnings season underway, investors are closely watching quarterly results for cues on market direction,” said Vinod Nair, Head of Research, Geojit Investments Limited.

On Friday, Indian equity benchmark indices ended higher for the second straight session, supported by strong buying in pharma and banking stocks.

Because of the weakness in IT stocks, the Sensex opened at 82,07,5 down about 100 points. But it quickly bounced back, rising 579 points to an intra-day high of 82,654.

At 82,501, the index ultimately closed 329 points higher, or 0.4 per cent higher. Likewise, the Nifty reached a peak of 25,331 during the day and ended the day 104 points, or 0.4 per cent, higher at 25,285.

“Investor sentiment improved after the government invited private sector professionals to lead the State Bank of India. This marks a broader policy shift towards allowing private participation in public sector enterprises, aimed at enhancing efficiency and governance,” Nair added.

The Nifty index displayed strong bullish momentum over the past week, advancing 391 points or 1.57 per cent, while Sensex rallied over 1,000 points or 1.35 per cent.

“On the weekly chart, the index has formed a cup and handle pattern, and a decisive break out of this formation, supported by increasing volumes, would signal the potential for further sustained upside,” said Hardik Matalia of Choice Equity Broking.

The Bank Nifty (up 1.84 per cent), Nifty IT (up 4.8 per cent) and Nifty Pharma (up 2.12 per cent) fueled the market momentum this week.

Continue Reading

Business

Sensex, Nifty edge higher as geopolitical tensions ease

Published

on

New Delhi, Oct 10: Indian stock markets opened on a flat note but soon moved higher on Friday, supported by positive global sentiment.

The easing of geopolitical tensions in the Middle East and signs of a possible trade deal between the US and India boosted investor confidence.

After the opening bell, the Sensex gained 148 points, or 0.18 per cent, to trade at 82,320 levels. The Nifty also rose 40 points, or 0.16 per cent, to 25,221 levels.

“Though yesterday’s push higher in the second half failed to clear the week’s high, it did serve to invalidate the bearish bias of the evening star candle stick pattern,” market experts said.

“This encourages us to look for 25460, in the days ahead. For the day, inability to push and float above 25215 or direct fall past 25113, could render the trend sideways, but may not call for a break of 24982 right away,” they added.

In the broader market, the Nifty Midcap 100 index inched up 0.18 per cent, while the Nifty Smallcap 100 advanced 0.28 per cent — indicating healthy participation from mid- and small-cap stocks.

Among the sectoral indices, Nifty Metal was the worst performer, slipping 1.4 per cent. It was followed by weakness in Auto, Pharma, and Healthcare stocks.

On the other hand, sectors such as Banking, Energy, FMCG, IT, Consumer Durables, Oil & Gas, and Realty were trading with gains.

In the Sensex pack, Power Grid, State Bank of India, NTPC, Adani Ports, and Asian Paints were among the top gainers.

Meanwhile, Tata Steel, TCS, Bajaj Finance, M&M, and HCL Tech were trading in the red.

“The overall market environment is turning positive. Globally, the GAZA peace accord signals end to the conflict and reduction of geopolitical risk from the region,” analysts said.

“Domestically, there are indications of a trade deal between US and India with India ‘rebalancing’ its oil purchases,” they added.

According to market analysts, these positive developments and the shift in FII strategy ( FIIs were buyers in the cash market in the last three trading days) bode well for the market.

Continue Reading
Advertisement
Advertisement

Trending